Clinical Trials Browser

Phase 2/3 × Esophageal Neoplasms × Capecitabine × Clear all

NCT01404156 2024-08-28

POWERRANGER

Phase 2/3 Completed

Gastrointestinal

Adenocarcinoma Of Esophagus, Adenocarcinoma, Esophageal Neoplasms

NCT02741856 2018-10-25

SCOPE2

Phase 2/3 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT00509561 2012-12-18

Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer

Phase 2/3 Unknown

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms